On the recordFebruary 1, 2017
I am going to pretty much direct this to Dr. Holtz-Eakin.
Source
congress.govI am going to pretty much direct this to Dr. Holtz-Eakin.
Indicating focus on a specific witness during questioning.
Share & report
More from Chris Collins
The reality is that the landscape of the cost of drugs, especially in the oncology world... has gotten into some of the biologics and the treatments, which are great for any and all of these patients.
Shouldn't you change your charter then or ask us to--there is always the issue. It is there for a reason and you are just ignoring it.
I think we are just all frustrated. There seems to be the bureaucracy mindset in the DEA today, much like we've seen in the VA.
This isn't a time to be polite or nice or let's do better tomorrow. No, this is an abject failure.